The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Angiogenesis in Endocrine Tumors
Abstract
Angiogenesis is the process of new blood vessel development from preexisting vasculature. Although vascular endothelium is usually quiescent in the adult, active angiogenesis has been shown to be an important process for new vessel formation, tumor growth, progression, and spread. The angiogenic phenotype depends on the balance of proangiogenic growth factors such as vascular endothelial growth factor (VEGF) and inhibitors, as well as interactions with the extracellular matrix, allowing for endothelial migration. Endocrine glands are typically vascular organs, and their blood supply is essential for normal function and tight control of hormone feedback loops. In addition to metabolic factors such as hypoxia, the process of angiogenesis is also regulated by hormonal changes such as increased estrogen, IGF-I, and TSH levels. By measuring microvascular density, differences in angiogenesis have been related to differences in tumor behavior, and similar techniques have been applied to both benign and malignant endocrine tumors with the aim of identification of tumors that subsequently behave in an aggressive fashion. In contrast to other tumor types, pituitary tumors are less vascular than normal pituitary tissue, although the mechanism for this observation is not known. A relationship between angiogenesis and tumor size, tumor invasiveness, and aggressiveness has been shown in some pituitary tumor types, but not in others. There are few reports on the role of microvascular density or angiogenic factors in adrenal tumors. The mechanism of the vascular tumors, which include adrenomedullary tumors, found in patients with Von Hippel Lindau disease has been well characterized, and clinical trials of antiangiogenic therapy are currently being performed in patients with Von Hippel Lindau disease. Thyroid tumors are more vascular than normal thyroid tissue, and there is a clear correlation between increased VEGF expression and more aggressive thyroid tumor behavior and metastasis. Although parathyroid tissue induces angiogenesis when autotransplanted and PTH regulates both VEGF and MMP expression, there are few studies of angiogenesis and angiogenic factors in parathyroid tumors. An understanding of the balance of angiogenesis in these vascular tumors and mechanisms of vascular control may assist in therapeutic decisions and allow appropriately targeted treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,608
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Risau, W., & Flamme, I. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000445 · Cited by 1,406
Fibroblast growth factors, their receptors and signaling
Powers, C. J., McLeskey, S. W., & Wellstein, A. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070165 · Cited by 1,332
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,221
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Angiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
Anti-Angiogenesis: New Concept for Therapy of Solid Tumors
Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,171
SIGNALLING BY RECEPTOR TYROSINE KINASES
Fantl, W. J., Johnson, D. E., & Williams, L. T. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002321 · Cited by 1,086
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Self-citationTumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“Inhibitors of angiogenesis such as angiostatin and endostatin reduce tumor growth if administered at this early stage, suggesting that increasing angiogenesis is important to tumor progression (26).”
BackgroundTissue Inhibitor of Metalloproteinase (TIMP-2)
Stetler-Stevenson, W. G., Krutzsch, H. C., & Liotta, L. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71503-2 · Cited by 895
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Relf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K. A., Leek, R., Moghaddam, A., Whitehouse, R. M., Bicknell, R., & Harris, A. L. (1997) · PubMed · Cited by 833
Self-citationAntiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Zou, H., McGarry, T. J., Bernal, T., & Kirschner, M. W. (1999) · Science · doi:10.1126/science.285.5426.418 · Cited by 805
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
Horak, E. R., Klenk, N., Leek, R., LeJeune, S., Smith, K., Stuart, N., Harris, A. L., Greenall, M., & Stepniewska, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)93150-l · Cited by 800
Self-citationMäkinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M. I., Pulkkanen, K. J., Kauppinen, R., Jackson, D. G., Kubo, H., Nishikawa, S.-I., et al. (2001) · Nature Medicine · doi:10.1038/84651 · Cited by 777
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.
Frank, S., Hübner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., & Werner, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12607 · Cited by 764
Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., Mcculloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., et al. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00379-6 · Cited by 729
Self-citationPertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., & Ferrara, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117857 · Cited by 694
Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes & Development · doi:10.1101/gad.12.21.3320 · Cited by 647
Nör, J. E., Christensen, J., Mooney, D. J., & Polverini, P. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65284-4 · Cited by 641
Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., & Dvorak, H. F. (1993) · PubMed · Cited by 635
Vascular endothelial growth factor is essential for corpus luteum angiogenesis
Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., Chisholm, V., Hillan, K. J., & Schwall, R. H. (1998) · Nature Medicine · doi:10.1038/nm0398-336 · Cited by 624
Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Guidi, A. J., Dvorak, H. F., Senger, D. R., Connolly, J. L., & Schnitt, S. J. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90119-1 · Cited by 619
The Matrix Metalloproteinases and Their Inhibitors
Murphy, G., & Docherty, A. J. P. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.2.120 · Cited by 597
Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
Stetler‐Stevenson, W. G., Liotta, L. A., & Kleiner, D. E. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.15.8262328 · Cited by 596
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues.
Holthöfer, H., Virtanen, I., Kariniemi, A. L., Hormia, M., Linder, E., & Miettinen, A. (1982) · PubMed · Cited by 577
Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG)
Pei, L. (1997) · Molecular Endocrinology · doi:10.1210/me.11.4.433 · Cited by 576
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575
Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., & Senger, D. R. (1993) · PubMed · Cited by 564
Olofsson, B., Korpelainen, E., Pepper, M. S., Mandriota, S. J., Aase, K., Kumar, V., Gunji, Y., Jeltsch, M. M., Shibuya, M., Alitalo, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11709 · Cited by 560
Smith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Deckers, M. M. L. (2000) · Endocrinology · doi:10.1210/en.141.5.1667 · Cited by 552
Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell’Era, P., Nico, B., Roncali, L., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.8.2627 · Cited by 538
Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., & Linehan, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10589 · Cited by 531
Angiostatin binds ATP synthase on the surface of human endothelial cells
Moser, T. L., Stack, M. S., Asplin, I., Enghild, J. J., Højrup, P., Everitt, L., Hubchak, S., Schnaper, H. W., & Pizzo, S. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2811 · Cited by 526
Vascular endothelial growth factor and the regulation of angiogenesis.
Ferrara, N. (2000) · PubMed · Cited by 524
Xin, X., Yang, S., Kowalski, J., & Gerritsen, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9116 · Cited by 513
Structure and Function of VEGF/VEGF-receptor System Involved in Angiogenesis.
Shibuya, M. (2001) · Cell Structure and Function · doi:10.1247/csf.26.25 · Cited by 504
Aliello, L. P. (1995) · Medical Entomology and Zoology · Cited by 463
Stein, I., Neeman, M., Shweiki, D., Itin, A., & Keshet, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5363 · Cited by 455
Vascular Growth Factors and Lymphangiogenesis
Jussila, L., & Alitalo, K. (2002) · Physiological Reviews · doi:10.1152/physrev.00005.2002 · Cited by 443
Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas
Zhang, X. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.761 · Cited by 440
Fox, S. B., Leek, R. D., Weekes, M. P., Whitehouse, R. M., Gatter, K. C., & Harris, A. L. (1995) · The Journal of Pathology · doi:10.1002/path.1711770310 · Cited by 436
Self-citationPatterson, B. C., & Sang, Q. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28823 · Cited by 433
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.
Rosenberg, C. L., Wong, E., Petty, E. M., Bale, A. E., Tsujimoto, Y., Harris, N. L., & Arnold, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9638 · Cited by 432
Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor Prognosis
Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S.-C., Skinner, D. G., & Nichols, P. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1603 · Cited by 420
Tie receptors: new modulators of angiogenic and lymphangiogenic responses
Jones, N., Iljin, K., Dumont, D. J., & Alitalo, K. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067005 · Cited by 418
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., & Strawn, L. M. (1996) · PubMed · Cited by 413
Bunone, G., Vigneri, P., Mariani, L., Butó, S., Collini, P., Pilotti, S., Pierotti, M. A., & Bongarzone, I. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65515-0 · Cited by 404
Basu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
Smith, L. E. H., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., & Schaeffer, J. M. (1997) · Science · doi:10.1126/science.276.5319.1706 · Cited by 393
Bernhard, E. J., Gruber, S. B., & Muschel, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4293 · Cited by 385
Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., & Keshet, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10820 · Cited by 374
Mukai, K., Rosai, J., & Burgdorf, W. H. C. (1980) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198006000-00008 · Cited by 374
Toi, M., Inada, K., Suzuki, H., & Tominaga, T. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666040 · Cited by 362
Vascular endothelial growth factor
Ferrara, N. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00387-5 · Cited by 355
Li, J., Perrella, M. A., Tsai, J.-C., Yet, S.-F., Hsieh, C.-M., Yoshizumi, M., Patterson, C., Endege, W. O., Zhou, F., & Lee, M.-E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.308 · Cited by 346
Angiogenesis in the female reproductive system
Reynolds, L. P., Killilea, S. D., & Redmer, D. A. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.3.1371260 · Cited by 345
Structural and functional analysis of hypoxia-inducible factor 1
Semenza, G. L., Agani, F., Booth, G., Forsythe, J., Iyer, N., Jiang, B.-H., Leung, S., Roe, R., Wiener, C., & Yu, A. (1997) · Kidney International · doi:10.1038/ki.1997.77 · Cited by 343
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/en.133.3.1292 · Cited by 340
Angiogenesis in female reproductive system
Longjiang, Shao, S., Cheng, & Zhu (2001) · 中国科学通报:英文版 · Cited by 339
Heaney, A. P., Horwitz, G. A., Wang, Z., Singson, R., & Melmed, S. (1999) · Nature Medicine · doi:10.1038/15275 · Cited by 337
Self-citationVisconti, R. P., Richardson, C. D., & Sato, T. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122109599 · Cited by 335
Burrows, F. J., Derbyshire, E. J., Tazzari, P. L., Amlot, P. L., Gazdar, A. F., King, S. W., Letarte, M., Vitetta, E. S., & Thorpe, P. E. (1995) · PubMed · Cited by 334
Complex role of matrix metalloproteinases in angiogenesis
Sang, Q. X. A. (1998) · Cell Research · doi:10.1038/cr.1998.17 · Cited by 332
Inducible regulatory elements in the human cyclin D1 promoter.
Herber, B., Truss, M., Beato, M., & Müller, R. (1994) · PubMed · Cited by 309
Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny‐Baron, G., & Marmé, D. (1996) · PubMed · Cited by 308
Functional grafts of the anterior pituitary gland
Harris, G. W., & Jacobsohn, D. (1952) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1952.0011 · Cited by 307
Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
Goede, V., Schmidt, T., Kimmina, S., Kozian, D. H., & Augustin, H. G. (1998) · PubMed · Cited by 299
Zucker, S., Lysik, R. M., Zarrabi, M. H., & Moll, U. M. (1993) · PubMed · Cited by 296
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10868 · Cited by 292
S100 protein in folliculostellate cells of the rat pituitary anterior lobe
Nakajima, T., Yamaguchi, H., & Takahashi, K. (1980) · Brain Research · doi:10.1016/0006-8993(80)91300-1 · Cited by 290
Expression of vascular endothelial growth factor in digestive neuroendocrine tumours
Terris, Scoazec, Rubbia, Bregeaud, Pepper, Ruszniewski, Belghiti, FLÉjou, & Degott (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00321.x · Cited by 279
Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D’Angelo, G., Goffin, V., Weiner, R. I., & Martial, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1246 · Cited by 279
Vascular endothelial grouth facter B, a novel growth facter for endothelial cells
Olffson, B. (1996) · Medical Entomology and Zoology · Cited by 279
Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1
Delgrange, E., Trouillas, J., Maiter, D., Donckier, J., & Tourniaire, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4088 · Cited by 277
Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., & Donner, D. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29483 · Cited by 274
Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B., & Fini, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10405 · Cited by 274
Angiogenesis in human coronary atherosclerotic plaques.
O’Brien, E. R., Garvin, M. R., Dev, R., Stewart, D. K., Hinohara, T., Simpson, J. B., & Schwartz, S. M. (1994) · PubMed · Cited by 271
Hyder, S. M., Nawaz, Z., Chiappetta, C., & Stancel, G. M. (2000) · PubMed · Cited by 268
Demonstration and characterization of the angiogenic properties of cervical dysplasia.
Smith‐McCune, K., & Weidner, N. (1994) · PubMed · Cited by 264
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand‐Apte, B., Pepper, M. S., Voest, E. E., Montesano, R., Olsen, B. R., Murphy, G., Apte, S., & Zetter, B. R. (1997) · PubMed · Cited by 251
Tumor angiogenesis as a predictor of recurrence in gastric carcinoma.
Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., & Arimoto, Y. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.477 · Cited by 246
Quantitation of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane
Nguyen, M., Shing, Y., & Folkman, J. (1994) · Microvascular Research · doi:10.1006/mvre.1994.1003 · Cited by 243
Structural aspects of the permeability of the microvascular endothelium.
Palade, G. E., Simionescu, M., & Simionescu, N. (1979) · PubMed · Cited by 243
Nauck, M., Roth, M., Tamm, M., Eickelberg, O., Wieland, H., Stulz, P., & Perruchoud, A. P. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.4.9115750 · Cited by 241
Trikha, M., Zhao, Z., Tímár, J., Raso, E., Kennel, M., Emmell, E., & Nakada, M. T. (2002) · PubMed · Cited by 237
Franck-Lissbrant, I., Häggström, S., Damber, J.-E., & Bergh, A. (1998) · Endocrinology · doi:10.1210/endo.139.2.5683 · Cited by 236
Vartanian, R. K., & Weidner, N. (1994) · PubMed · Cited by 232
Ruohola, J. K., Valve, E. M., Karkkainen, M. J., Joukov, V., Alitalo, K., & Härkönen, P. L. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00003-9 · Cited by 230
D'Angelo, G., Struman, I., Martial, J., & Weiner, R. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6374 · Cited by 227
A Portal Circulation from the Pituitary to the Hypothalamic Region.
POPA, G. T. (1930) · PubMed · Cited by 226
Bergland, R. M., & Page, R. B. (1979) · Science · doi:10.1126/science.373118 · Cited by 224
Gicquel, C. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1444 · Cited by 224
Goad, D. L. (1996) · Endocrinology · doi:10.1210/en.137.6.2262 · Cited by 217
Miele, C., Rochford, J. J., Filippa, N., Giorgetti-Peraldi, S., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000805200 · Cited by 216
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.
Colville-Nash, P. R., & Scott, D. L. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.7.919 · Cited by 213
FERRARA, N., CLAPP, C., & WEINER, R. (1991) · Endocrinology · doi:10.1210/endo-129-2-896 · Cited by 212
Hua, J., & Muschel, R. J. (1996) · PubMed · Cited by 211
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer.
Fox, S. B., Gatter, K. C., Bicknell, R., Going, J. J., Stanton, P. D., Cooke, T. G., & Harris, A. L. (1993) · PubMed · Cited by 210
Self-citationHoshino, M., Takahashi, M., Takai, Y., & Sim, J. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70379-9 · Cited by 210
Pituitary follicular cells produce basic fibroblast growth factor.
Ferrara, N., Schweigerer, L., Neufeld, G., Mitchell, R., & Gospodarowicz, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5773 · Cited by 200
Lin, P. C., Sankar, S., Shan, S. Q., Dewhirst, M. W., Polverini, P. J., Quinn, T. Q., & Peters, K. G. (1998) · PubMed · Cited by 199
Christofori, G. (1995) · Molecular Endocrinology · doi:10.1210/me.9.12.1760 · Cited by 198
Gately, S. T., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L. N., Cundiff, D. L., Schnaper, H. W., Madison, L. D., Volpert, O. V., Bouck, N., et al. (1996) · PubMed · Cited by 197
Schlingemann, R. O., Rietveld, F. J. R., de Waal, R. M. W., Bradley, N. J., Skene, A., Davies, A. J., Greaves, M. F., Denekamp, J., & Ruiter, D. J. (1990) · PubMed · Cited by 196
Kim, K., Bae, S. K., Lee, O., Bae, M.-H., Lee, M. J., & Park, B. C. (1998) · PubMed · Cited by 190
Angiogenesis as a marker of preneoplastic lesions of the human breast
Brem, S. S., Jensen, H. M., & Gullino, P. M. (1978) · Cancer · doi:10.1002/1097-0142(197801)41:1<239::aid-cncr2820410133>3.0.co;2-x · Cited by 189
Mañes, S., Llorente, M., Lacalle, R. A., Gómez-Moutón, C., Kremer, L., Mira, E., & Martı́nez-A, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6935 · Cited by 188
Dunk, C., Shams, M., Nijjar, S., Rhaman, M., Qiu, Y., Bussolati, B., & Ahmed, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65089-4 · Cited by 187
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I
Punglia, R. S., Lu, M., Hsu, J., Kuroki, M., Tolentino, M. J., Keough, K., Levy, A. P., Levy, N. S., Goldberg, M. A., D'Amato, R. J., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.10.1619 · Cited by 187
Nickoloff, B. J., Mitra, R. S., Varani, J., Dixit, V. M., & Polverini, P. J. (1994) · PubMed Central · Cited by 186
The start of a long debate on the Warnock report.
Deitch, R. (1984) · PubMed · Cited by 186
Akagi, Y., Liu, W., Zebrowski, B. K., Xie, K., & Ellis, L. M. (1998) · PubMed · Cited by 184
A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues
Wang, J. M., Kumar, S., Pye, D., Krupinski, J., Hunter, R. D., & Van Agthoven, A. J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540303 · Cited by 183
Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., & Okada, Y. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.4.991 · Cited by 182
Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study
Delgrange, E. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2102 · Cited by 181
Sato, K., Yamazaki, K., Shizume, K., Kanaji, Y., Obara, T., Ohsumi, K., Demura, H., Yamaguchi, S., & Shibuya, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118164 · Cited by 179
Thrombospondins and tumor angiogenesis
de Fraipont, F., Nicholson, A. C., Feige, J.-J., & Van Meir, E. G. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02102-5 · Cited by 178
Clapp, C., & Weiner, R. I. (1992) · Endocrinology · doi:10.1210/endo.130.3.1311239 · Cited by 167
Tumor Angiogenesis: Iris Neovascularization at a Distance From Experimental Intraocular Tumors2
Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/50.1.219 · Cited by 165
MELNYK, O., ZIMMERMAN, M., KIM, K. J., & SHUMAN, M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61829-9 · Cited by 162
COX‐2 Inhibitors: A New Class of Antiangiogenic Agents
Masferrer, J. L., Koki, A. T., & Seibert, K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08726.x · Cited by 159
Urı́a, J. A., Ferrando, A. A., Velasco, G., Freije, J. M. P., & López-Otı́n, C. (1994) · PubMed · Cited by 159
Jackson, C., & Nguyen, M. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00061-7 · Cited by 158
Peters, K., Coogan, A., Berry, D., Marks, J., Iglehart, J., Kontos, C., Rao, P., Sankar, S., & Trogan, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.8 · Cited by 158
Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors.
Elias, K. A., & Weiner, R. I. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4549 · Cited by 156
HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS
Greene, H. S. N. (1941) · The Journal of Experimental Medicine · doi:10.1084/jem.73.4.461 · Cited by 156
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder, S. M., Murthy, L. J., & Stancel, G. M. (1998) · PubMed · Cited by 156
Klein, M., Picard, E., Vignaud, J.-M., Marie, B., Bresler, L., Toussaint, B., Weryha, G., Duprez, A., & Leclere, J.-C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610041 · Cited by 155
Nakamura, H., Ueno, H., Yamashita, K., Shimada, T., Yamamoto, E., Noguchi, M., Fujimoto, N., Sato, H., Seiki, M., & Okada, Y. (1999) · PubMed · Cited by 154
Soh, E. Y., Duh, Q., Sobhi, S. A., Young, D. M., Epstein, H. D., Wong, M. G., Garcia, Y. K., Min, Y. D., Grossman, R. F., SIPERSTEIN, A. E., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4340 · Cited by 154
Ivan, M., BOND, J. A., Prat, M., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201083 · Cited by 152
Takigawa, M., Nishida, Y., Suzuki, F., et al. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90822-5 · Cited by 151
From angiogenesis to lymphangiogenesis
Plate, K. H. (2001) · Nature Medicine · doi:10.1038/84579 · Cited by 146
McGregor, L. M., McCune, B. K., Graff, J. R., McDowell, P. R., Romans, K. E., Yancopoulos, G. D., Ball, D. W., Baylin, S. B., & Nelkin, B. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4540 · Cited by 146
Beitner‐Johnson, D., & Millhorn, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19834 · Cited by 144
Giatromanolaki, A. N., Koukourakis, M. I., Kakolyris, S., Turley, H., O'Byrne, K. J., Scott, P. A. E., Pezzella, F., Georgoulias, V., Harris, A. L., & Gatter, K. C. (1998) · PubMed · Cited by 142
Self-citationWojta, J., Kaun, C., Breuss, J. M., Koshelnick, Y., Beckmann, R., Hattey, E., Mildner, M., Weninger, W., Nakamura, T., Tschachler, E., et al. (1999) · PubMed · Cited by 139
Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases
Fowlkes, J. L., Thrailkill, K. M., Serra, D. M., Suzuki, K., & Nagase, H. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00017-8 · Cited by 138
Akita, S., Webster, J., Ren, S. G., Takino, H., Said, J., Zand, O., & Melmed, S. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117779 · Cited by 138
Self-citationDobbs, S. P., Hewett, P., Johnson, I., Carmichael, J., & Murray, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.571 · Cited by 137
Yamakawa, K., Hosoi, M., Koyama, H., Tanaka, S., Fukumoto, S., Morii, H., & Nishizawà, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2665 · Cited by 136
Human Pituitary Tumor-Transforming Gene Induces Angiogenesis1
Ishikawa, H., Heaney, A. P., Yu, R., Horwitz, G. A., & Melmed, S. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7184 · Cited by 135
Self-citationIruela‐Arispe, M. L., Porter, P. L., BORNSTEIN, P. K., & Sage, E. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118429 · Cited by 134
New perspectives in the function of pituitary folliculo-stellate cells
Allaerts, W., Carmeliet, P., & Denef, C. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90244-3 · Cited by 133
Prognostic markers in pheochromocytoma
Clarke, M. R., Weyant, R. J., Watson, C. G., & Carty, S. E. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90070-3 · Cited by 131
Long‐term follow‐up of patients with hyperprolactinaemia
Jeffcoate, W. J., Pound, N., Sturrock, N. D. C., & Lambourne, J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00824.x · Cited by 129
Ferrara, N., Winer, J., & Henzel, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.698 · Cited by 129
Wang, D. S., Yamazaki, K., Nohtomi, K., SHIZUME, K., Ohsumi, K., Shibuya, M., Demura, H., & Sato, K. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110408 · Cited by 124
Angiogenesis Induced by "Normal" Human Breast Tissue: A Probable Marker for Precancer
Jensen, H. M., Chen, I., DeVault, M. R., & Lewis, A. E. (1982) · Science · doi:10.1126/science.6181563 · Cited by 122
Iitaka, M., Miura, S., Yamanaka, K., Kawasaki, S., Kitahama, S., Kawakami, Y., Kakinuma, S., Oosuga, I., Wada, S., & Katayama, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5281 · Cited by 118
Soh, E. Y., Sobhi, S. A., Wong, M. G., Meng, Y. G., SIPERSTEIN, A. E., Clark, O. H., & Duh, Q. (1996) · Surgery · doi:10.1016/s0039-6060(96)80038-9 · Cited by 118
Banerjee, S. K. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1155 · Cited by 117
Machein, Kullmer, Rönicke, Machein, Krieg, Damert, Breier, Risau, & Plate (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00166.x · Cited by 113
Fenton, C., Patel, A. D., Dinauer, C., Robie, D. K., Tuttle, R. M., & Francis, G. L. (2000) · Thyroid · doi:10.1089/thy.2000.10.349 · Cited by 110
Loss of ovarian function promotes angiogenesis in human ovarian carcinoma
Schiffenbauer, Y. S., Abramovitch, R., Meir, G., Nevo, N., Holzinger, M., Itin, A., Keshet, E., & Neeman, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13203 · Cited by 109
Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
Griscelli, F., Li, H., Cheong, C., Opolon, P., Griscelli, A. B., Vassal, G., Soria, J., Soria, C., Lu, H., Perricaudet, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110134297 · Cited by 108
Clapp, C., Torner, L., Gutiérrez‐Ospina, G., Alcántara, E., López-Gómez, F. J., Nagano, M. C., Kelly, P. A., Mejía, S., Morales, M. A., & de la Escalera, G. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10384 · Cited by 108
Lozonschi, L., Sunamura, M., Kobari, M., Egawa, S., Ding, L., & Matsuno, S. (1999) · PubMed · Cited by 107
Rosenberg, C. L., Motokura, T., Kronenberg, H. M., & Arnold, A. (1993) · PubMed · Cited by 107
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
Kulke, M. H., Lenz, H.-J., Meropol, N. J., Posey, J., Ryan, D. P., Picus, J., Bergsland, E., Stuart, K., Tye, L., Huang, X., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9020 · Cited by 623
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Kloos, R. T., Ringel, M. D., Knopp, M. V., Hall, N. C., King, M., Stevens, R., Liang, J., Wakely, P. E., Vasko, V. V., Saji, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2717 · Cited by 541
Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
Vaupel, P. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s3-21 · Cited by 383
Metadata
- Authors
- Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-10-01
- Volume
- 24
- Issue
- 5
- Pages
- 600-632
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2125153669
- Cited by
- 275
- References
- 296
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.